Electromed Inc.
| AMEX: ELMD | Healthcare / Medical Devices & Instruments / USA |
| 10.43 | +0.4000 | +3.99% | Vol 5.93K | 1Y Perf -18.92% |
| Mar 24th, 2023 16:00 DELAYED |
| BID | 8.30 | ASK | 14.00 | ||
| Open | 10.23 | Previous Close | 10.03 | ||
| Pre-Market | - | After-Market | - | ||
| - - | - -% |
| Target Price | 16.75 | Analyst Rating | Strong Buy 1.00 | |
| Potential % | 60.59 | Finscreener Ranking | ★★★★★ 60.04 | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★★★★+ 59.43 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★★★★+ 65.24 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 33.01 | Earnings Rating | Buy | |
| Market Cap | 88.80M | Earnings Date | 9th May 2023 | |
| Alpha | 0.01 | Standard Deviation | 0.13 | |
| Beta | 0.67 |
Today's Price Range 10.0310.49 | 52W Range 8.7513.84 | 5 Year PE Ratio Range 17.2085.80 |
Summary:
Sell
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | 3.17% | ||
| 1 Month | -20.98% | ||
| 3 Months | 5.46% | ||
| 6 Months | 3.17% | ||
| 1 Year | -18.92% | ||
| 3 Years | -14.51% | ||
| 5 Years | 91.73% | ||
| 10 Years | 609.52% |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | 6.53 | |||
ROE last 12 Months | 5.80 | |||
ROA (5Y Avg) | 4.18 | |||
ROA last 12 Months | 4.99 | |||
ROC (5Y Avg) | 6.98 | |||
ROC last 12 Months | 5.75 | |||
Return on invested Capital Q | 0.23 | |||
Return on invested Capital Y | 6.87 | |||
Assets Turnover | 0.30 | |||
Receivables Turnover | 0.70 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 47.40 | ||||
| 2.59 | ||||
| 2.77 | ||||
| 107.60 | ||||
| -26.90 | ||||
| -0.21 | ||||
| 2.59 | ||||
| 4.02 | ||||
| 82.54M | ||||
| Forward PE | 27.29 | |||
| PEG | 5.54 |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 4.60 | ||||
| 5.60 | ||||
| - | ||||
| 0.00 | ||||
| - | ||||
| Leverage Ratio | 1.20 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 75.80 | ||||
| 5.90 | ||||
| 7.30 | ||||
| 11.80 | ||||
| 3.46 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 32.07M | ||||
| 3.78 | ||||
| 4.04 | ||||
| 8.41 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q02 2023 | - | 0.11 | - |
| Q01 2023 | - | 0.01 | - |
| Q04 2022 | - | 0.04 | - |
| Q03 2022 | - | 0.07 | - |
| Q02 2022 | 0.07 | 0.10 | 42.86 |
| Q01 2022 | 0.06 | 0.05 | -16.67 |
| Q04 2021 | 0.04 | 0.04 | 0.00 |
| Q03 2021 | 0.06 | 0.03 | -50.00 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 3/2022 QR | 0.05 | -83.87 | Negative |
| 3/2022 QR | 0.13 | 0.00 | - |
| 6/2022 FY | 0.26 | -44.68 | Negative |
| 6/2023 FY | 0.37 | - | - |
| Next Report Date | 9th May 2023 |
| Estimated EPS Next Report | - |
| Estimates Count | - |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 5.93K |
| Shares Outstanding | 8.51K |
| Shares Float | 7.09M |
| Trades Count | 177 |
| Dollar Volume | 60.72K |
| Avg. Volume | 16.24K |
| Avg. Weekly Volume | 17.24K |
| Avg. Monthly Volume | 17.06K |
| Avg. Quarterly Volume | 14.42K |
Electromed Inc. (AMEX: ELMD) stock closed at 10.43 per share at the end of the most recent trading day (a 3.99% change compared to the prior day closing price) with a volume of 5.93K shares and market capitalization of 88.80M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 120 people. Electromed Inc. CEO is Kathleen S. Skarvan.
The one-year performance of Electromed Inc. stock is -18.92%, while year-to-date (YTD) performance is -0.57%. ELMD stock has a five-year performance of 91.73%. Its 52-week range is between 8.75 and 13.84, which gives ELMD stock a 52-week price range ratio of 33.01%
Electromed Inc. currently has a PE ratio of 47.40, a price-to-book (PB) ratio of 2.59, a price-to-sale (PS) ratio of 2.77, a price to cashflow ratio of 107.60, a PEG ratio of 2.32, a ROA of 4.99%, a ROC of 5.75% and a ROE of 5.80%. The company’s profit margin is 3.46%, its EBITDA margin is 7.30%, and its revenue ttm is $32.07 Million , which makes it $3.78 revenue per share.
Of the last four earnings reports from Electromed Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Electromed Inc.’s next earnings report date is 09th May 2023.
The consensus rating of Wall Street analysts for Electromed Inc. is Strong Buy (1), with a target price of $16.75, which is +60.59% compared to the current price. The earnings rating for Electromed Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Electromed Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Electromed Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 21.30, ATR14 : 0.63, CCI20 : -82.44, Chaikin Money Flow : -0.30, MACD : -0.53, Money Flow Index : 31.71, ROC : -14.79, RSI : 37.62, STOCH (14,3) : 13.29, STOCH RSI : 1.00, UO : 29.51, Williams %R : -86.71), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Electromed Inc. in the last 12-months were: Kathleen S. Skarvan (Option Excercise at a value of $124 650)
Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets and sells innovative products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
CEO: Kathleen S. Skarvan
Telephone: +1 952 758-9299
Address: 500 Sixth Avenue NW, New Prague 56071, MN, US
Number of employees: 120
